Venrock Healthcare Capital Partners II, L.P. - Jun 10, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role
10%+ Owner
Signature
/s/ David L. Stepp, Authorized Signatory
Stock symbol
TCDA
Transactions as of
Jun 10, 2022
Transactions value $
$1,011,461
Form type
4
Date filed
6/14/2022, 05:00 PM
Previous filing
Jun 9, 2022
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCDA Common Stock Purchase $517K +58.1K +0.9% $8.91* 6.51M Jun 10, 2022 By Funds F1, F2, F3
transaction TCDA Common Stock Purchase $407K +50K +0.77% $8.14* 6.56M Jun 13, 2022 By Funds F3, F4, F5
transaction TCDA Common Stock Purchase $87.2K +10K +0.15% $8.72* 6.57M Jun 14, 2022 By Funds F3, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 15,262 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 1,527 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 41,265 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.76 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.
F4 Consists of (i) 1,762 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 713 shares purchased by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 12,494 shares purchased by VHCP III, (iv) 1,249 shares purchased by VHCP Co-3 and (v) 33,782 shares purchased by VHCP EG.
F5 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F6 Consists of (i) 2,629 shares purchased by VHCP III, (ii) 263 shares purchased by VHCP Co-3 and (iii) 7,108 shares purchased by VHCP EG.
F7 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.60 to $8.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.